- Article
MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1
- Khadijeh Mahboobnia,
- Tasnuva D. Kabir,
- Rui Hou,
- Peiwen Liu,
- Alistair Forrest,
- Dianne J. Beveridge,
- Kirsty L. Richardson,
- Lisa M. Stuart,
- George C. Yeoh and
- Peter J. Leedman
Resistance to tyrosine kinase inhibitors (TKIs, e.g., sorafenib and lenvatinib) presents a significant hurdle for hepatocellular carcinoma (HCC) treatment, underscoring the need to decipher the underlying mechanisms for improved therapeutic strategie...